Pharmacy News

July 11, 2019

• Gamunex-C 10% Consumer Level Withdrawal

July 10, 2019

• Altaire Pharmaceuticals, Inc. Voluntary Recall of Multiple Ophthalmic Products Sold at CVS

July 5, 2019

• Parkinson Disease Drug Pulled

July 5, 2019

• Sedative Injection Recalled

July 5, 2019

• lSurgical Injection Recalled

July 3, 2018

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Walgreens

July 3, 2019

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products

July 3, 2019

• Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection

July 1, 2019

• Safety Communication for Certain Medtronic MiniMed Insulin Pumps

July 1, 2019

• SmartSite Syringe Administration Set Recall

June 28, 2019

• Gamunex-C 10% Consumer Level Withdrawal

June 27, 2018

• Cetirizine Oral Solution Recalled

June 27, 2018

• Breast Cancer Drug Recalled

June 27, 2018

• enFlow Fluid Warming System Disposable Cartridge Recall

June 25, 2019

• Losartan Potassium and Losartan HCTZ Recall

June 20, 2019

• Heparin Sodium in Dextrose Recall

June 20, 2019

• Zyflo CR Recall

June 20, 2019

• Pecgen DMX Cough Suppressant Expectorant (Class I) Recall

May 29, 2019

• CVS Brand Meds Recalled

May 29, 2019

• Recall Active for Promacta

May 29, 2019

• Over 170,000 Bottles of Prescription Laxative Recalled

May 23, 2019

• Additional Recalls issued for Losartan Potassium Tablets

May 11, 2019

• Novartis Issues Voluntary Nationwide Recall of Promacta

May 9, 2019

• Four Firms Issue New Recalls for Losartan

May 9, 2019

• Diabetes Drug Recalled

May 9, 2019

• Class II Recall Active for Hydromorphone

May 9, 2019

• Recall Active for Bevacizumab

April 4, 2019

• FDA Recalls Fayosim Tablets

April 4, 2019

• Class II Recall Active for Combigan

March 30, 2019

• Kingston Pharma recalls Nautrals baby cough syrup plus mucus

March 30, 2019

• Hypertension Drug Recalled

March 30, 2019

• Antibiotic Eye Drops Recalled

March 4, 2019

• FDA Issues Safety Alert for JAK Inhibitor

March 4, 2019

• Apotex Corp Issues Voluntary Recall of Drospirenone and Ethinyl Estradiol Tablets

March 1, 2019

• Aurobindo Pharmaceuticals Limited Issues Valsartan Amlodipine Tablets Recall

February 28, 2019

• Camber Pharmaceuticals Limited Issues Losartan Potassium Recall

February 22, 2019

• Macleods Pharmaceuticals Limited Issues Losartan Potassium/HCT Recall

February 8, 2019

• Antibiotic Recalled

February 8, 2019

• Hypertension Drug Recalled

February 8, 2019

• Antihistamine Pulled

February 8, 2019

• Blood Pressure-Water Pill Recalled

February 4, 2019

• Medex Cardio Pulmonary recalls Sterile Saline and Sterile Water

February 3, 2019

• Blood Thinner Recalled

February 2, 2019

• Topical Steroid Recalled

February 2, 2019

• Cholesterol Drug Recalled

February 1, 2019

• Terrific Care LLC Medex Supply Recalls CoaguCheck XS Test Strips

January 18, 2019

• Surgical Muscle Relaxant Pulled in Class I Recall

January 18, 2019

• Oral Suspension Antibiotic Recalled

January 18, 2019

• Intravitreal Corticosteroid Implant Recalled

January 18, 2019

• Class I Recall of Antibiotic Injection

January 1, 2019

• New Opioid Prescription Safety Measures

December 7, 2018

• Acne Cream Recalled Over Impurities

December 7, 2018

• Antipsychotic Drug Recalled

December 7, 2018

• Anemia Injection Recalled

December 7, 2018

• FDA alerts health care professionals and patients not to use drug products intended to be sterile from Promise Pharmacy

December 5, 2018

• Infant Ibuprofen Recalled

December 4, 2018

• Mylan expands Voluntary Recall of Valsartan

December 4, 2018

• Blood Thinner Pulled

November 30, 2018

• Chewable Antacids Recalled

November 30, 2018

• Mylan to Recall All Batches of Blood Pressure Medicine Valsartan in US

November 8, 2018

• Nationwide Recall of Losartan

November 8, 2018

• Opioid Solution recalled

November 8, 2018

• Analgesic Solution Recalled

November 8, 2018

• Hypertension Drug Recalled

November 2, 2018

• Epi-Pen Alert

November 2, 2018

• Diuretic Recalled

November 2, 2018

• Antibiotic Injection Recalled

November 2, 2018

• Skin Solution Recalled

November 2, 2018

• Intravenous Antiviral Recalled

November 2, 2018

• Beta Blocker Pulled

October 12, 2018

• Class l Recall for Muscle Relaxant

October 12, 2018

• Steroid-Antifungal Cream Recalled

October 12, 2018

• Biopharmaceutical Recalled

October 12, 2018

• Antipsychotic Pulled

September 27, 2018

• Muscle Relaxant Pulled After Diabetes Drug Found.

September 27, 2018

• Over 15,000 Bottles of Anticonvulsant Recalled.

August 24, 2018

• Contaminant Prompts Recall of Ace Inhibitor

August 24, 2018

• Chemotherapy Drug Recalled

August 24, 2018

• Recall of Blood Pressure Drug Expands

August 23, 2018

• Updated additional lots added-Torrent Pharmaceuticals

August 10, 2018

• Antibiotic Tablets Recalled

August 10, 2018

• Antibiotic Vials Recalled

August 10, 2018

• NSAID Capsules Pulled

August 9, 2018

• Camber Pharmaceuticals-Valsartan Recall

August 9, 2018

• Levothyroxine and Liothyronine Recall

July 31, 2018

• AuroMedicas Piperacillin/Tazobactam Injection Recall

July 27, 2018

• Antibiotic Recall

July 27, 2018

• Multiple Pain Killers Pulled

July 27, 2018

• Blood Pressure Med Recalled

July 27, 2018

• Epinephrine Injection Recalled

July 27, 2018

• Diabetes Tablets Recalled

July 17, 2018

• Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

July 17, 2018

• Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

July 13, 2018

• Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)

May 31, 2018

• Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall – Due to the Potential Presence of Particulate Matter

June 4, 2018

• Fluticasone Propionate Nasal Spray by Apotex Corp: Recall – Due to Potential for Small Glass Particless

March 5, 2018

• Hydromorphone HCL Injection USP by Hospira: Recall – Potential For Empty Or Cracked Glass Vials

February 16, 2018

• Two Injectable Drugs Recalled

February 16, 2018

• Class I Recall: Injectable Antibiotic

February 13, 2018

• Acyclovir 400mg Tablets by Apace Packaging: Recall – Product Mix-up

February 7, 2018

• COPD Inhaler Capsules Recalled

February 1, 2018

• Expansive Ibuprofen Recall

February 1, 2018

• Class II Statin Recall

February 1, 2018

• Cancer Drug Recalled

January 26, 2018

• Chemotherapy Drug Recalled

January 26, 2018

• Antiseizure Tablets Recalled

January 26, 2018

• Statin Recalled

January 19, 2018

• Dozens of Compounded Preparations Recalled

January 19, 2018

• Hypertension Drug Recalled

January 16, 2018

• Safety Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter – Anaphylaxis and Other Serious Hypersensitivity Reactions

January 12, 2018

• Safety Alert: Becton-Dickinson (BD) Syringes Used to Store Compounded or Repackaged Drugs: FDA Alert – Problematic Rubber Stoppers Replaced

January 12, 2018

• Prefilled Injections Shipped with Wrong Drug

January 12, 2018

• Class I Recall: Prescription Diarrhea Med

January 12, 2018

• Recall: Depression Drug

January 10, 2018

• Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall – Product Mislabeling

January 5, 2018

• Compounded Injectable Drugs Recalled

December 28, 2017

• Class I and II Recall Active for Prescription Med

December 28, 2017

• Class I Antibiotic Recall

December 28, 2017

• Class I Recall Issued for Anxiety Med

December 22, 2017

• Diabetes Med Recalled

December 15, 2017

• Class I Recall Issued for Antidepressants Labelled as Statins

December 8, 2017

• Depression Med Bottles May Contain Antipsychotic

December 8, 2017

• Prescription Schizophrenia Med Recalled

December 1, 2017

• Inhaled Vasodilator Recalled

December 1, 2017

• Depression Treatment Recalled

November 27, 2017

• Riomet (Metformin Hydrochloride Oral Solution): Recall – Microbial Contamination

November 17, 2017

• Antiseptic Swabsticks Recalled

November 17, 2017

• Skeletal Muscle Relaxant Recalledg

November 17, 2017

• Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall – Possible Sub Potent and Super Potent Tablets

November 10, 2017

• Over 140,000 Bottles Recalled of Prostate Drug

November 3, 2017

• Multiple Pain Meds Recalled

November 3, 2017

• Compounded Injection Recalled

November 2, 2017

• Arrhythmia Drug Recalled.

October 27, 2017

• Injectable Corticosteroid Recalled.

October 27, 2017

• High Blood Pressure Med Recalled.

October 10, 2017

• Prescription NSAID Recalled.

September 22, 2017

• Recall Active for Serotonin Reuptake Inhibitor.

September 21, 2017

• Prescription Cancer Treatment Recalled.

September 19, 2017

• Nationwide Eye Drops Recall.

September 18, 2017

• Patient Death Prompts Recall.

September 8, 2017

• Prescription Antibiotic Recalled – Morton Grove Pharmaceuticals Inc. is recalling 7332 bottles of amoxicillin and clavulanate potassium for oral suspension, USP, 250/62.5 mg per 5 mL, 100 mL when reconstituted (NDC 60432-065-00).

September 7, 2017

• Nationwide Opioid Recall – The possibility of leaky containers has prompted Tris Pharma Inc. to voluntarily recall morphine sulfate oral solution, 100 mg/5 mL (20 mg/mL) (NDC 27808-082-01).

August 15, 2017

• Seizure Medication Recalled – A labeling mix-up has prompted Precision Dose Inc. to voluntarily recall carbamazepine oral suspension, USP, 100 mg/5 mL, 5-mL unit dose cups (NDC 68094-301-59).

August 15, 2017

• Antibiotic Recall Active – Sterility concerns have prompted SCA Pharmaceuticals to recall cefazolin 3 g added to 100 mL 0.9% sodium chloride, total approximate volume 115 mL, single-dose container bags (NDC 70004-0524-32).

August 9, 2017

• International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A.

August 9, 2017

• SCA Pharmaceuticals is recalling hydromorphone 0.5 mg/mL in 0.9% sodium chloride 1-mL fill in 3-mL Becton Dickinson syringe (NDC 70004-0302-05), due to lack of assurance of sterility; product has the potential to leak.

July 28, 2017

• Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging: Recall – Potential Mislabeling

June 15, 2017

• Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall to Consumer/User Level for One Lot of Paliperidone Extended-Release Tablets, 3mg, 90 Count Bottles Distributed Under the Actavis Pharma Inc. Label Due to Dissolution Test Failure

June 14, 2017

• Topical Products by Phillips Company: Recall – Due to Concerns of Manufacturing Practices

June 10, 2017

• Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

May 26, 2017

• Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 – Due to Report of Another Medicine in One Bottle

May 25, 2017

• Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas™ 24 Fe (Norethindrone Acetate and EthinylEstradiol 1mg/0.02mg Chewable Tablets and Ferrous Fumarate 75 mg) Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information

April 21, 2017

• Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall – Labeling Error on Declared Strength

April 4, 2017

• GSK recalling nearly 600,000 Ventolin inhalers in U.S.

March 31, 2017

• FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

January 18, 2017

• Injectionn for Infants Recalled: 10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only

January 17, 2017

• Gastrointestinal Stimulant Recalled: Tri-Coast Pharmacy, Dexpanthenol 250 mg/mL (30 ML)

January 13, 2017

• Soluble Vitamin Recalled: Tri-Coast Pharmacy, Ascorbic Acid 500 mg/mL (50 ML)

January 13, 2017

• Prostaglandin Recalled: Alprostadil 20 mcg/mL Injectable vials. The ongoing, Class II recall affects both 5-mL and 10-mL vials distributed throughout the United States

January 13, 2017

• Decongestant Recalled: Wells Pharmacy Network LLC issued a nationwide recall of nearly 2000 5-mL vials of Phenylephrine HCl Injectable, 1 mg/mL (0.1%)

January 11, 2017

• Multivitamin IV Recalled

January 9, 2017

• Antifungal Injection Recalled

January 6, 2017

• Class I Recall of Dietary Supplement

January 5, 2017

• Anti-Cancer Medication Recalled

January 4, 2017

• Class I Recall of Constipation Med.

January 2, 2017

• Paralytic Drug Recalled.

December 28, 2016

• Narcotic Injection Recalled.

December 22, 2016

• Anticoagulant Recalled: Cantrell Drug Company is recalling 1494 syringes of Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride.

December 16, 2016

• Erectile Dysfunction Injection Recalled: Fallon Wellness Pharmacy, LLC, is recalling 10 1-mL vials of PAPA/PHEN/PROST (papaverine/phentolamine/prostaglandin) 18 mg/0.6 mg/0.006 mg/mL Injection.

December 11, 2016

• Antiemetic Drug Recalled – India-based drug manufacturer Cadila Pharmaceuticals Limited has recalled 6 kg of its Ondansetron HCL API,

December 9, 2016

• Diabetes Medication Recalled – Ascend Laboratories LLC is recalling 1739 1000-count bottles of Metformin Hydrochloride Tablets, USP 500 mg, due to the presence of foreign tablets.

November 10, 2016

• Muscle Relaxer Recall – PharMEDium Services, LLC, initiated a nationwide recall of succinylcholine chloride, 20 mg/mL, 200 mg/10 mL, 10-mL vials

October 5, 2016

• Lansoprazole Recalled

September 28, 2016

• SSRI Recalled

September 16, 2016

• Virtus Pharmaceuticals Opco II, LLC Issues Voluntary Nationwide Recall of Hyoscyamine sulfate Due to Superpotent and Subpotent Results

September 14, 2016

• Selegiline Recalled

September 14, 2016

• ADHD Medication Recalled

September 8, 2016

• Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

August 4, 2016

• Seizure Medication Recalled: Divalproex sodium delayed-release tablets, USP, 250 mg., failed specifications

July 28, 2016

• Acetaminophen Overdose Antidote Recalled

July 22, 2016

• 35 Lots of Antidepressant Capsules Recalled

July 16, 2016

• Oral Liquid Docusate Sodium by PharmaTech: Recall – Contaminated with B. Cepacia

May 18, 2016

• Dr. Reddy’s recalls 50,000 bottles of Ondansetron tablets in US

April 26, 2016

• Prescription Coverage to Treat Hepatitis C Update: We updated our medical necessity criteria for coverage of Hepatitis C treatment and you may now be eligible for coverage. Under our revised policy, we will no longer restrict coverage based upon fibrosis levels.

March 28, 2016

• Compounded Products by Reliable Drug Pharmacy: Recall – Potential for Mislabeling and Lack of Quality Assurance

March 21, 2016

• Recall: Sodium Bicarbonate Injection, USP by Hospira: Recall – Particulate Matter

March 9, 2016

• Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL) Vials Due to Glass Particulate Matter

March 7, 2016

• Recall: Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall – Elevated Impurity

February 17, 2016

• Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall – Super-potent Product

January 11, 2016

• Perrigo Initiates Voluntary Product Recall in the U.S. Of Children’s Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid Due to a Potential Defect with the Dosage Cup

October 30, 2015

• Sanofi US Issues Voluntary Nationwide Recall of ALL Auvi‑Q® Due to Potential Inaccurate Dosage Delivery

August 24, 2015

• Allergan Issues Voluntary Nationwide Recall In The U.S. Of Specific Lots Of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (Sulfacetamide Sodium And Prednisolone Acetate Ophthalmic Ointment, USP) 10%/0.2% For Particulate Matter

August 18, 2015

• Merck Recalls Temodar® and Temozolomide Capsules (generic) Bottles with Cracked Caps in the U.S. Due to Failure to Meet Child-Resistant Closure Requirement

August 4, 2015

• Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall – Potential Presence of Foreign Tablets Contamination

May 5, 2015

• Recall: Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL) – Particulate Matter

April 23, 2015

• Mylan Initiates Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter

April 9, 2015

• Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter

November 21, 2014

• Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules

October 31, 2014

• 10 Percent Neutral Buffered Formalin by Richard-Allan Scientific: Class I Recall – May Contain Incorrect Concentration of Formalin

October 20, 2014

• Kaiser Permanente® Issues Voluntary  Recall of Venlafaxine 37.5 mg ER tablets Manufactured by Sun  Pharmaceuticals, LTD

October 22, 2014

• Assured Brand Naproxen Sodium Tablets by Contract Packaging Resources, Inc.: Recall – Packaging Mix-Up

October 3, 2014

• Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Ketorolac Tromethamine Injection, USP, 30mg/ml Due to Labeling the Product with the Incorrect Expiration Date

April 2014

• First Time Generics (PDF)

March 6, 2014

• Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer’s Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone’s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules

January 17, 2013

• Advance Pharmaceutical Issues Nationwide Voluntary recall of one Lot (# 12G468) of Ferrous Sulfate Tablets, 325 mg, that may actually contain Meclizine HCl 25 mg tablets